Matteo Giulietti

2.1k citations
54 papers · 1.5k indexed · h-index 21
Topics
Extracellular vesicles in disease (9 papers)RNA modifications and cancer (9 papers)MicroRNA in disease regulation (8 papers)
Partner nations
ItalyUnited StatesSpain

In The Last Decade

Matteo Giulietti

52 papers receiving 1.5k citations

Peers

Matteo Giulietti
Comparison fields: 5 of 110
  • Molecular Biology 1.1k
  • Cancer Research 560
  • Pulmonary and Respiratory Medicine 366
  • Oncology 229
  • Immunology 97
Replace Alisha Parveen with:
Alisha Parveen Germany
Jianqing Wu China
Sho Koyasu Japan
Matteo Morello Italy
Yujia Lan China
Jinyuan Xu China
Yanyan Ping China
Masashi Idogawa Japan
Aiai Shi China
Yuanbin Ru United States
Matteo Giulietti relative to Alisha Parveen Germany Alisha Parveen's profile →
Citations per field
00.5×50×119×
Alisha Parveen · 1×
Citations per year

Countries citing papers authored by Matteo Giulietti

Since Specialization
Citations

This map shows the geographic impact of Matteo Giulietti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matteo Giulietti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matteo Giulietti more than expected).

Fields of papers citing papers by Matteo Giulietti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matteo Giulietti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matteo Giulietti. The network helps show where Matteo Giulietti may publish in the future.

Co-authorship network of co-authors of Matteo Giulietti

This figure shows the co-authorship network connecting the top 25 collaborators of Matteo Giulietti. A scholar is included among the top collaborators of Matteo Giulietti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matteo Giulietti. Matteo Giulietti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 2
3 1
4 2
5 14
6 13
7 20
8 9
9 36
10 35
11 30
12 20
13 43
14 65
15 47
16 102
17 1
18 109
19 5
20 3

About Matteo Giulietti

Matteo Giulietti is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 54 papers that have together received 1.5k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (9 papers), RNA modifications and cancer (9 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Cancer Research (560 citations), Molecular Biology (1.1k citations) and Pulmonary and Respiratory Medicine (366 citations). Matteo Giulietti has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Francesco Piva, Giovanni Principato, Giulia Occhipinti, Monia Cecati, Matteo Santoni, Rodolfo Montironi, Francesco Piva, Linda Nocchi, Liang Cheng and Marina Scarpelli. Their work appears in journals such as Nucleic Acids Research, Bioinformatics and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026